Theme:
Light Dark Auto
GeneralPoliticsBusinessTechnologyEnvironmentSportsEntertainment
HEALTH
Negative Sentiment

United States tennis icon Chris Evert faces renewed ovarian cancer battle

Read, Watch or Listen

United States tennis icon Chris Evert faces renewed ovarian cancer battle

Chris Evert, the 71-year-old American tennis Hall of Famer and ESPN analyst, has announced that her ovarian cancer has returned. In a statement released on Thursday, June 25, 2026, via her social media accounts, Evert said recent CT and PET scans detected the recurrence. She has already undergone surgery and plans to begin another course of chemotherapy in the coming weeks. As a result, Evert will miss the 2026 Wimbledon Championships in London and will pause all professional duties to focus on treatment. This is her third ovarian cancer diagnosis, following initial detection in December 2021 and a recurrence in December 2023.

Prepared by Olivia Bennett and reviewed by editorial team.

Timeline of Events

  • December 2021 Evert receives initial ovarian cancer diagnosis
  • January 2023 Evert announces she is cancer free
  • December 2023 Cancer recurrence prompts further treatment
  • Past weekend 2026 CT PET scans show new recurrence
  • Recent days 2026 Evert undergoes surgery for recurrence
  • June 25 2026 Evert publicly announces cancer return
  • June 25 2026 Confirms withdrawal from 2026 Wimbledon duties
  • Coming weeks 2026 Chemotherapy course scheduled to begin

News Intelligence

  • Chris Evert's battle with ovarian cancer is a stark reminder of the disease's persistence. It's a wake-up call to prioritize regular health check-ups, especially for women over
  • 5
  • Early detection can make a significant difference in treatment and survival rates.

Coverage of Story:

From Left

No left-leaning sources found for this story.

From Center

United States tennis icon Chris Evert faces renewed ovarian cancer battle

JQJO
From Right

No right-leaning sources found for this story.

Related News

Comments

JQJO App
Get JQJO App
Read news faster on our app
GET